Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02271711Phase 1Completed
Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors
Recurrent Childhood MedulloblastomaRecurrent EpendymomaRecurrent Medulloblastoma
PrincipalinvestigatorStart date: 2015-03-17

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

M.D. Anderson Cancer Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Donald W Parsons

Children's Oncology Group

Related
1 trials

Shared therapeutic areas:

Recurrent EpendymomaRecurrent Medulloblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Andrea T Franson

Children's Oncology Group

Related
1 trials

Shared therapeutic areas:

Recurrent EpendymomaRecurrent Medulloblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Matthias Karajannis, MD, MS

Memorial Sloan Kettering Cancer Center

Related
1 trials

Shared therapeutic areas:

Recurrent EpendymomaRecurrent Medulloblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Katherine A Janeway

Children's Oncology Group

Related
2 trials

Shared therapeutic areas:

Recurrent EpendymomaRecurrent Medulloblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Theodore W Laetsch

Children's Oncology Group

Related
2 trials

Shared therapeutic areas:

Recurrent EpendymomaRecurrent Medulloblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Tobey MacDonald

Pediatric Brain Tumor Consortium

Related
1 trials

Shared therapeutic areas:

Recurrent Childhood Medulloblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

David I Sandberg, MD

The University of Texas Health Science Center, Houston

Related
2 trials

Shared therapeutic areas:

Recurrent Ependymoma
Similarity Score10%

Ziad Khatib, MD

Nicklaus Children's Hospital

Related
2 trials

Shared therapeutic areas:

Recurrent Childhood Medulloblastoma
Similarity Score10%

Maryam Fouladi

Children's Oncology Group

Related
5 trials

Shared therapeutic areas:

Recurrent Childhood Medulloblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Amar Gajjar

Pediatric Brain Tumor Consortium

Related
4 trials

Shared therapeutic areas:

Recurrent Childhood Medulloblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02271711Phase 1PrincipalInvestigator

Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors

Recurrent Childhood MedulloblastomaRecurrent EpendymomaRecurrent Medulloblastoma
Completed

All 1 trials loaded